From quid pro quo to quid pro bono: reshaping the influence of industry on health care epidemiologists.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19951230.
- Also identified by DOI 10.1086/648723.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent scrutiny of relationships between medical professionals and the pharmaceutical and medical device industries has highlighted many opportunities for conflicts of interest and has prompted calls for reforms in the way we conduct such business. This article reviews ways in which industry influences health care epidemiologists and considers a range of strategies that might be considered for reshaping these influences to preserve the benefits while eliminating the conflicts of interest.
Medical subject headings
- Drug Industry
- Epidemiology
- Health Care Sector
- Health Personnel